Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study

Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study

William B Saunders,1 Hiep Nguyen,2 Iftekhar Kalsekar2 1Department of Public Health Sciences, College of Health and Human Services, The University of North Carolina at Charlotte, Charlotte, NC, 2AstraZeneca, Fort Washington, PA, USA Aim: The glucagon-like peptide-1 receptor agonists exenatide once we...

Full description

Bibliographic Details
Main Authors: Saunders WB, Nguyen H, Kalsekar I
Format: Article
Language:English
Published: Dove Medical Press 2016-07-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Diabetes
exenatide
outcomes
Online Access:https://www.dovepress.com/real-world-glycemic-outcomes-in-patients-with-type-2-diabetes-initiati-peer-reviewed-article-DMSO

Similar Items

Similar Items